News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Miguel Sieler Head Of Neovasc Inc. (NVC): "We Develop A Groundbreaking Technology"


6/19/2014 10:30:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS, June 19, 2014 (GLOBE NEWSWIRE) -- Neovacs, (Alternext Paris: ALNEV), is a leader in active immunotherapies for the treatment of autoimmune diseases. The company will participate to the first annual "French Life Sciences Days", a major event that will bring together French biotech and medtech companies listed on the NYSE Euronext exchange, on 25 & 26 June, with members of the French and North American financial community. In this TV interview, Miguel Sieler Neovacs CEO explained the strategy of the company for US investors.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES